AVI BioPharma appoints new senior VP and CFO
This article was originally published in Scrip
AVI BioPharma(US), a developer of RNA-based drugs, has appointed David Boyle senior vice-president and chief financial officer. Mr Boyle is expected to join the company on August 18th, at which time, Mark Webber, the company's current CFO, will assume a new position within AVI as general manager of finance and administration. Mr Boyle was previously vice-president of finance and chief financial officer at Xoma.